Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 7/20/2020CDE Issues the Clinical Research Guidelines for Trastuzumab Biosimilar...
  • 7/20/2020CDE Issues the Guideline on the Submission of Clinical Trial Data
  • 7/17/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...
  • 7/16/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...
  • 7/14/2020CDE Solicits Comments on the Draft Technical Guidelines for Pharmaceut...
  • 7/14/2020CDE Issues the Guidelines for Drug Clinical Trials During Novel Corona...
  • 7/10/2020CDE Launches Updated Drug Clinical Trial Registration and Information ...
  • 7/10/2020CDE Launches Online Application Systems for Breakthrough Medicines and...
  • 7/9/2020CDE Issues the Guidelines for Format/Style and Collation of Drug Admin...
  • 7/8/2020NMPA Issues the Working Procedure for Priority Review and Approval of ...
  • 7/8/2020NMPA Issues Working Procedures for Drug Marketing Evaluation and Appro...
  • 7/8/2020NMPA Issues Working Procedures for Evaluation and Approval of Breakthr...
  • 7/6/2020CDE Solicits Comments on the Draft Writing Guide and Common Format of ...
  • 7/6/2020CDE Solicits Comments on the Draft Technical Guidelines for Marketing ...
  • 7/6/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...
  • 7/3/2020CDE Issues Interim Guidelines for Registration Acceptance and Evaluati...
  • 7/2/2020NIFDC Issues the Guideline for the Working Procedures and Technical Re...
  • 7/2/2020NMPA and NHC Introduce the 2020 Edition of Chinese Pharmacopoeia
  • 7/2/2020NMPA Issues the Amended Blood Product Appendix of 2010 GMP
  • 7/1/2020CDE Solicits Comments on the Draft CDE Guidelines for Management of Su...
  • 7/1/2020CDE Issues the M4 Module 1. Administrative Information and Prescribing...
  • 7/1/2020CDE Issues the Guidelines for Safety Update Reporting During R&amp...
  • 7/1/2020CDE Issues the Guidelines for Evaluation and Management of Safety Info...
  • 7/1/2020CDE Issues the Guidelines for Clinical Trial Registration and Informat...
  • 7/1/2020NMPA Issues the Requirements for Drug Record and Data Management (Inte...
  • 7/1/2020NMPA Issues Announcement on Drug Registration Fee Standards and Rules
  • 7/1/2020NMPA Reports on Crackdown of Fake and Substandard Drugs in 2019
  • 6/30/2020NMPA Issues the Chemical Drug Registration Classification and Dossier ...
  • 6/30/2020NMPA Issues the Biologic Product Registration Classification and Dossi...
  • 6/30/2020NMPA Publicizes the List of Reference Formulations for Generic Drug Eq...
  • Page:4/9 Total number of articles:247: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group Support by: www.heightow.com